 - Patients receiving systemic administration, or topical application to the head or face including instillation to the eyes of any steroid, nonsteroidal anti-inflammatory drug, antiphlogistic enzyme, immunosuppressive drug or colchicine within 1 week prior to the start of the study treatment 